Coming December: ASH publishes its late-breaking abstracts. We’ll add the organizations presenting them.

UMass Chan Medical School at ASH 2026

Dec 12–15, 2026 New Orleans, LA ~30k attendees Website

UMass Chan Medical School brings 6 presentations to ASH 2026 in New Orleans. Its research spans myelodysplastic syndromes, CAR T-cell therapy and transplant. Work covers TP53-mutant relapse after transplant, infections after CAR T therapy and risk in transformed follicular lymphoma.

OrganizationASH 2026 Attendance
Universities & research institutes
Public medical school of the University of Massachusetts in Worcester.
Session
Fri Dec 11
3:00pm–6:00pm
Scientific Workshop on TP53: A Moving Target
Mutations in the p53 gene bring a very poor outlook in myeloid cancers, and this workshop follows them from first mutation to therapy.
Leukemias

Explore the full ASH 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in New Orleans. Leave your work email and we’ll be in touch.

Privacy

Download the full ASH 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at UMass Chan Medical School

Tell us what you sell and we’ll find the people at UMass Chan Medical School most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the American Society of Hematology (ASH). Submit a correction